pipette
ENEnglish

Why Have Drug Names Become So Weird? A Retrospective Analysis of the Orthographic Distinctiveness of Proprietary and Generic Names Across Four Decades of FDA Approvals

B. L. Lambert

PreprintInterés amplio

En palabras de los autores

Background. Regulatory pressure to avoid confusingly similar drug names appears to have pushed manufacturers to coin more distinctive proprietary names, but no one has quantitatively analyzed this trend. Objective. To determine whether proprietary drug names became more orthographically distinctive (unusual in spelling) over time. Methods. We examined 1,321 US Food and Drug Administration (FDA) new molecular entity (NME) names (1985-2024), 2,769 FDA Orange Book trade names (1982-2026), 177,337 US pharmaceutical trademarks (1980-2026), and 1,273 generic names (1982-2025). Compared to prior names (including those already marketed) and ordinary English, we scored each name's character trigram (three-letter sequence) surprisal (statistical unexpectedness) and its edit-distance similarity to the closest existing names. Linear regression tested time trends, controlling for name length. Results. Mean NME trigram surprisal rose in every decade between the 1980s and 2020s, from 7.21 to 8.50 nats (natural-logarithm units, higher meaning less predictable), an 18% increase (b = 0.038, p < .001, R2 = 0.34). Half of 2020s names (7% in the 1980s) contained a letter sequence found in no common English word (e.g., Jesduvroq, Omvoh). Nearest-neighbor similarity fell after the early 1990s. Trademark data showed the same trend (b = 0.016, p < .001). Generic names showed a weaker trend (b = 0.011, R2 = 0.063). Conclusions. Over four decades, drug names became more orthographically distinctive, consistent with namespace crowding, deliberate efforts to avoid confusing names, and branding strategy. Because unfamiliar letter sequences can introduce other error pathways, increased distinctiveness does not necessarily imply improved safety.

Resultado principalLimitación que admiten los autores

En palabras simples Resumen con IA

Midieron qué tan inusual era la ortografía de cada nombre usando pruebas estadísticas. Los nombres de medicamentos de marca se volvieron 18% más distintivos en ortografía durante cuatro décadas. La mitad de los nombres de la década de 2020 contenían secuencias de letras que no se encuentran en ninguna palabra común del inglés. Los autores señalan que una ortografía más distintiva no necesariamente significa mayor seguridad.

Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale. Se eliminó 1 oración por no estar respaldada por el abstract.

Apareció: sábado, 17 de octubre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.15.26365645